Vysioneer is an oncology AI company with a mission to use machine learning to bring therapies to cancer patients in need sooner. Our journey began with the belief that every tumor matters in the fight against cancer.

Powered by our FDA-cleared, cloud-based AI platform, Vysioneer enhances drug efficacy with lesion-level precision, enabling pharma and clinicians to identify the right treatment for the right patient at the right time. Vysioneer is headquartered in Cambridge, MA.


Jen-Tang (JT) Lu
Jen-Tang (JT) Lu, PhD


Roger W. Ferguson, Jr.
Roger W. Ferguson, Jr., J.D., PhD
Business advisor
Former President and CEO at TIAA
Joe Chang
Joe Chang, ScD
Business Advisor
Ex-Flatiron Health and Ex-IQVIA
Christopher Ballesteros
Christopher Ballesteros
Business advisor
Chief Commercial Officer, KangarooHealth Inc.
Chih-Han Yu
Chih-Han Yu, PhD
Business Advisor
Co-founder and CEO, Appier
Lawrence Leighton
Lawrence Leighton, MBA
Business Advisor
Managing Director, Bentley Associates
Peter Steiger
Peter Steiger, PhD
Business Advisor
Former Chief Scientific Officer, CALYX
Erqi Pollom
Erqi Pollom, MD
Medical Advisor
Radiation Oncologist, Stanford Cancer Center
Raymond Y. Huang
Raymond Y. Huang, MD, PhD
Medical Advisor
Division Chief, Neuroradiology, Brigham and Women's Hospital
Jason Cheng
Jason Cheng, MD, PhD
Medical Advisor
Former Division Chief, Radiation Oncology, National Taiwan University Hospital
Ryan King
Ryan King, MD
Medical Advisor
Neuroradiologist, LCMC Health


Join a team of world-leading experts passionate about making a global impact on cancer care through leading innovations built from scratch.

Full-Stack Software Engineer
Taipei, Taiwan, Full-Time
Lead, Life Sciences Partnerships
Cambridge, MA, Full-Time
Machine Learning Scientist
Taipei, Taiwan, Full-Time
PM and Quality Assurance/Regulatory Affairs
Taipei, Taiwan, Full-Time